US 7223844
Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes
granted A61KA61K2039/505A61P
Quick answer
US patent 7223844 (Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/14, A61P31/18